Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineHLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the otherIdentification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motifRelative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesMultiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic miceDefinition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.Retrovirus reverse transcriptases containing a modified YXDD motif.Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.Cytokine-adjuvanted HIV-DNA vaccination strategies.In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine.Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopesCreating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications.Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope.Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.Control of M184V HIV-1 mutants by CD8 T-cell responses.Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors
P2860
Q21092234-2CFF21E1-F1F6-4360-88BC-57D5362E364AQ33787144-17BD3622-7761-4A0A-BD91-918A2A3EB590Q33836117-05FCC971-20CF-4974-BB3D-17897D18CFEBQ33842771-EC8235DE-44BA-48EC-B7A5-B8479938CAB7Q33849127-18C73A9F-5D47-433A-A7FA-8EEB52238FF0Q34717892-E3CE52BF-4F30-4C80-B933-3F30CEB922E2Q35139305-7FE25916-67B8-453E-B93A-AE89BB87D06AQ35871440-3E79301F-34D9-444A-9899-48FE4BDDFFE2Q36186797-85B1C581-284E-47FE-B136-3D1148B1C7B1Q36259730-0AC0AE08-7FA7-4873-AEE1-4B6BBDE425A9Q36629899-9B93AEBB-0C46-4BFE-8952-0B1A3BAD8751Q37099813-3D1ACBD9-C3F5-47D1-A1FD-F490A9C55195Q37363548-421AF5E9-AA9C-4065-9FA2-82FFF64C4E5DQ37382996-0C42BE2C-CFB5-4065-BEF6-0592FC0EE056Q38638346-D1A1DBF6-A40F-489B-9115-64166B94DD3CQ39539955-D440E900-51AF-4F75-ABEC-6F8B1EDBBC81Q39794217-0AA2486D-4B0F-4C70-83AE-77091A39CC7AQ40857790-28111232-A006-441F-8E2F-F7D2E424C1EEQ41338135-955D7CBA-E671-467D-AE5F-0D4541F5A601Q43578138-678FAB77-21BC-41AC-9D86-EE0BC16FB637Q43760325-727723FF-892C-45FA-A352-5FF011656145Q54332318-05B69703-D923-49B4-ADB4-0EAD10951A1EQ58279255-6A346410-5B75-4A4F-98E6-3270F4E09EA9
P2860
Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Recognition of the highly cons ...... matic long-term nonprogressor.
@en
Recognition of the highly cons ...... matic long-term nonprogressor.
@nl
type
label
Recognition of the highly cons ...... matic long-term nonprogressor.
@en
Recognition of the highly cons ...... matic long-term nonprogressor.
@nl
prefLabel
Recognition of the highly cons ...... matic long-term nonprogressor.
@en
Recognition of the highly cons ...... matic long-term nonprogressor.
@nl
P2093
P356
P1476
Recognition of the highly cons ...... matic long-term nonprogressor.
@en
P2093
Buchbinder S
Feinberg M
Johnson RP
P304
P356
10.1093/INFDIS/173.2.476
P407
P577
1996-02-01T00:00:00Z